Title of article :
Effect of Zinc Supplement on Prevention of PPROM and Improvement of some
Pregnancy Outcomes in Pregnant Women with a History of PPROM: A Randomized
Double -Blind Controlled Trial
Author/Authors :
Farshbaf-Khalili Azizeh نويسنده MSc, Department of Midwifery, Faculty of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, Iran Farshbaf-Khalili Azizeh , Shahnazi Mahnaz نويسنده MSc, Instructor, Departement of Midwifery, Faculty of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, Iran Shahnazi Mahnaz , Azimi Shiva نويسنده Department of Midwifery, Faculty of Nursing and Midwifery,
Tabriz University of Medical Sciences, Tabriz, Iran
Abstract :
Background Preterm premature rupture of membrane (PPROM) prior to
37 weeks’ gestation is among the most common obstetrics problems, which
is associated with prenatal mortality and several maternal and neonatal
complications. History of PPROM is a risk factor for recurrence. Zinc
has an important effect on the strength of membranes by affecting
collagen [tensile] strength - a substance with immunity mechanism and
antioxidant properties. Objectives This study was conducted to
investigate the effect of zinc supplement on the prevention of PPROM and
improvement of some pregnancy outcomes in pregnant women with a history
of PPROM during the second trimester and the early third trimester.
Methods In this randomized, double-blind, controlled clinical trial, 108
healthy pregnant women (at gestational age of 16 - 30 weeks) with a
history of PPROM and singleton pregnancy were selected by convenience
sampling method in the Midwifery Clinic of Shahid Akbarabadi hospital in
Tehran, Iran, between 2014 and 2015. They were then divided into two
groups of placebo and zinc sulfate tablet (40 mg) recipient using
randomized block design. In total, 92 subjects completed the study. The
frequency of PPROM was regarded as the primary outcome, and frequency of
PROM, average gestational age at birth, average birth weight, and
average head circumference were considered as the secondary outcomes.
The statistical analysis was based on intent-to-treat principle. Results
There was no between-groups difference in terms of demographic and
pregnancy specifications. Results showed no significant between-groups
(zinc versus placebo recipient) difference (P > 0.05) in terms of
the frequency of preterm pregnancy (22% versus 33.3%), frequency of
PPROM (4.9% versus 11.8%), frequency of PROM (14.6% versus 17.6%),
average birth weight (3192.17 g versus 3080.52 g), average gestational
age at birth (38.2 weeks versus 37.2 weeks), and average head
circumference at birth (34.63 cm versus 34.81 cm). Conclusions According
to the results, daily intake of zinc sulfate (40 mg) by pregnant women
with a history of PPROM does not contribute to the prevention of PPROM
and PROM and improvement of average gestational age at birth and
anthropometric measurements.
Journal title :
Astroparticle Physics